Table 3.
Parameter, n/Na [%] | Budesonide MMX 9 mg n = 255 |
Placebo n = 255 |
---|---|---|
Total cortisol > 5 µg/dlb | ||
Baseline | 249/255 [97.6] | 241/255 [94.5] |
Week 2 | 146/244 [59.8] | 237/249 [95.2] |
Week 4 | 144/241 [59.8] | 233/242 [96.3] |
Week 8 | 150/225 [66.7] | 231/236 [97.9] |
Normal response to ACTH challengec | ||
Baseline | 222/248 [89.5] | 223/254 [87.8] |
Week 8 | 119/224 [53.1] | 202/236 [85.6] |
ACTH, adrenocorticotrophic hormone; MMX, multimatrix.
aDenominator N is the number of patients with a value at each given week during the study.
bLower limit of normal.
cDefined as increase from baseline in plasma cortisol concentration > 7 µg/dl, or plasma cortisol concentration > 18 µg/dl 30 min after ACTH challenge.